Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder
Sponsor: Yale University
Summary
This study will assess clinical and behavioral measures along with electroencephalogram (EEG), event-related potentials (ERPS), and eye-tracking (ET) prior to and following a single intermittent Theta Burst Stimulation (iTBS) session to provide preliminary insight into the potential of TMS as an intervention for depression in individuals with Autism Spectrum Disorder (ASD).
Official title: Neuromodulation for Depression in Autism Spectrum Disorder
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-04-30
Completion Date
2026-12
Last Updated
2025-07-02
Healthy Volunteers
Yes
Conditions
Interventions
MAGSTIM Rapid2 TMS system
The device will administer TMS pulses in bursts at fixed intervals for a total of 600 pulses over 190 seconds after first assessing the participants motor threshold (MT). During the sham stimulation condition, the TMS coil will be tilted 90° tangential to the scalp during the administration so that the orientation is not biologically active and will not elicit a muscle contraction. This sham condition will look and sound just like real TMS.
Locations (1)
Yale Psychiatric Hospital
New Haven, Connecticut, United States